A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

536

Participants

Timeline

Start Date

March 22, 2018

Primary Completion Date

March 18, 2020

Study Completion Date

March 18, 2020

Conditions
Type 2 Diabetes
Interventions
DRUG

LY2963016

Administered SC

DRUG

Lantus®

Administered SC

Trial Locations (32)

88798

Peking Union Medical College Hospital, Beijing

110022

Shengjing Hospital of China Medical University, Shenyang

116023

Dalian Med. Univ. No 2 Affiliate Hospital, Dalian

130041

No.2 Hospital Affiliated to Jilin University, Changchun

136000

Siping central people's hospital, Siping

200062

Shanghai Putuo District Center Hospital, Shanghai

210008

Nanjing Drum Tower Hosp Affiliated Hosp of Nanjing Univ Med, Nanjing

210011

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

210012

Nanjing First Hospital, Nanjing

210029

The First Affiliated Hospital with Nanjing Medical Universit, Nanjing

211199

Nanjing Jiangning Hospital, Nanjing

212001

Affiliated Hospital of Jiangsu University, Zhenjiang

213003

Changzhou No.2 People's Hospital, Changzhou

214023

Wuxi People's Hospital, Wuxi

214400

The Affliated Jiangyin Hospital of Southeast University Medical College, Jiangyin

221009

Xuzhou central Hospital, Xuzhou

230001

Anhui Provincial Hospital, Hefei

250013

Jinan Central Hospital, Jinan

300052

Tianjin Medical University General Hospital, Tianjin

400013

Chongqing General Hospital, Chongqing

414000

The First People Hospital of Yueyang, Yueyang

430014

Wuhan Central Hospital, Wuhan

430030

Tongji Hosp Tongji Med Col Huazhong Univ of Sci & Tech, Wuhan

471003

The 1st Affiliated Hospital of Henan Science and technology, Luoyang

510080

Guangdong Province People's Hospital, Guangzhou

The First Affiliated Hospital, Sun-Yat Sen University, Guangzhou

510120

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

515041

Shantou University Medical College No.2 Affiliated Hospital, Shantou

610041

West China Hospital of Sichuan University, Chengdu

730000

The First Affiliated Hospital of Lanzhou University, Lanzhou

750004

General Hospital of Ningxia Medical University, Yinchuan

030001

1st affiliated Hospital of Shanxi Medical University, Taiyuan

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03338010 - A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter